https://www.selleckchem.com/pr....oducts/cloperastine-
1% (95% CI 8.1-32.7%), = 45%, 17.7% (95% CI 1.8-71.9%), = 68%, and 16.7% (95% CI 3.0-56.5%, = 51% at week 8, 24, and 52, respectively. In this systematic review with meta-analysis, we found a signal of efficacy of ustekinumab on fistulizing pCD, emphasizing that these patients might benefit from this therapy. In this systematic review with meta-analysis, we found a signal of efficacy of ustekinumab on fistulizing pCD, emphasizing that these patients might benefit from this therapy. Positive emotions have been found to be